关于选举第七届董事会职工董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 美盈森集团股份有限公司（以下简称"公司"）已经启动第七届董事会换届 选举工作。根据《公司法》《公司章程》等有关规定，公司董事会包含职工董事 1 名，职工董事由公司职工通过职工代表大会、职工大会或者其他形式民主选举 产生，无需提交股东会审议。 为保障董事会正常运作，公司于 2025 年 11 月 21 日 14：00 起，在公司培训 室召开了公司职工代表大会，41 名职工代表参加了此次会议。经全体与会职工 代表表决，一致同意刘兰芳女士为公司第七届董事会职工董事，将与公司股东会 选举产生的第七届非职工董事共同组成公司第七届董事会，任期三年。 附职工董事简历。 特此公告。 美盈森集团股份有限公司董事会 2025 年 11 月 24 日 1 证券代码：002303 证券简称：美盈森 公告编号：2025-043 美盈森集团股份有限公司 关于选举第七届董事会职工董事的公告 关于选举第七届董事会职工董事的公告 刘兰芳女士简历： 刘兰芳女士，1984 年生，中国国籍，无境外永久居留权，大学本科 ...

美盈森集团股份有限公司 独立董事提名人声明与承诺 提名人美盈森集团股份有限公司董事会现就提名谭伟为美盈森集团股份有限公司 第 7 届董事会独立董事候选人发表公开声明。被提名人已书面同意作为美盈森集团股份 有限公司第 7 届董事会独立董事候选人。本次提名是在充分了解被提名人职业、学历、 职称、详细的工作经历、全部兼职、有无重大失信等不良记录等情况后作出的，本提名 人认为被提名人符合相关法律、行政法规、部门规章、规范性文件和深圳证券交易所业 务规则对独立董事候选人任职资格及独立性的要求，具体声明并承诺如下事项： 一、被提名人已经通过美盈森集团股份有限公司第 6 届董事会提名委员会或者独立 董事专门会议资格审查，提名人与被提名人不存在利害关系或者其他可能影响独立履职 情形的密切关系。 √是 □否 如否，请详细说明：______________________________ 三、被提名人符合中国证监会《上市公司独立董事管理办法》和深圳证券交易所业 务规则规定的独立董事任职资格和条件。 √是 □否 如否，请详细说明：______________________________ 四、被提名人符合公司章程规定的独立董事任 ...

美盈森集团股份有限公司 独立董事候选人声明与承诺 声明人谭伟作为美盈森集团股份有限公司第 7 届董事会独立董事候选人，已充分了 解并同意由提名人美盈森集团股份有限公司董事会提名为美盈森集团股份有限公司（以 下简称该公司）第 7 届董事会独立董事候选人。现公开声明和保证，本人与该公司之间 不存在任何影响本人独立性的关系，且符合相关法律、行政法规、部门规章、规范性文 件和深圳证券交易所业务规则对独立董事候选人任职资格及独立性的要求，具体声明并 承诺如下事项： 一、本人已经通过美盈森集团股份有限公司第 6 届董事会提名委员会或者独立董事 专门会议资格审查，提名人与本人不存在利害关系或者其他可能影响独立履职情形的密 切关系。 √是 □否 如否，请详细说明：______________________________ 二、本人不存在《中华人民共和国公司法》第一百七十八条等规定不得担任公司董 事的情形。 √是 □否 如否，请详细说明：______________________________ 如否，请详细说明：______________________________ 五、本人已经参加培训并取得证券交易所认可的相关培 ...

关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：公司 2025 年第二次临时股东会。 2、股东会召集人：公司第六届董事会。 公司第六届董事会第十五次（临时）会议审议通过了《关于提议召开 2025 年第二次临时股东会的议案》，同意召开本次股东会。 证券代码：002303 证券简称：美盈森 公告编号：2025-042 美盈森集团股份有限公司 关于召开 2025 年第二次临时股东会的通知 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市 公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有 关规定。 4、会议时间： （1）现场会议召开时间：2025 年 12 月 15 日 14:50 开始； （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 12 月 15 日 9:15—9:25，9:30—11:30 和 13:00—15:00；通过互联网 ...

第六届董事会第十五次（临时）会议决议公告 证券代码：002303 证券简称：美盈森 公告编号：2025-040 美盈森集团股份有限公司 第六届董事会第十五次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 美盈森集团股份有限公司（以下简称"公司"）第六届董事会第十五次（临时）会 议通知以电子方式于 2025 年 11 月 15 日送达。本次会议于 2025 年 11 月 21 日 10:00 起，在美盈森大厦 B 座 18 楼会议室以现场方式召开。本次会议应出席董事 6 人，实际 出席董事 6 人。公司高级管理人员列席了本次会议。会议的内容以及召集、召开的方式、 程序均符合《公司法》和《公司章程》的规定。会议由公司董事长王治军先生召集并主 持。 与会董事经过充分的讨论，一致通过以下决议： 一、以同意票 6 票，反对票 0 票，弃权票 0 票，审议通过了《关于修改<公司章程> 的议案》。 根据《中华人民共和国公司法》《深圳证券交易所股票上市规则（2025 年修订）》 《上市公司章程指引》等相关法律、法规及规章的规定，结合公司实际情况，董事会同 ...

Investment Rating - The industry investment rating is "Outperform" (maintained) [1] Core Viewpoints - The trend of packaging companies going overseas has shifted from an optional strategy to a necessary one due to intensified competition in the domestic market and changes in the international trade environment. The motivations for going overseas include responding to customer needs and industry chain shifts, as well as profit-driven and green/smart transformation initiatives. Key regions for expansion include Southeast Asia and Mexico, with a focus on light asset models and production line relocations to optimize profitability [4][5][6] Summary by Sections 1. Paper Packaging - The necessity for overseas expansion is driven by global supply chain migration and domestic low concentration leading to cost pressures. Companies are focusing on deep customer binding and local support [5][7] - Leading companies like Yutong Technology and Meiyingsen are expanding overseas, benefiting from early establishment in foreign markets and enjoying higher profit margins compared to domestic operations [21][24] - Investment recommendations include Yutong Technology and Meiyingsen for their strong overseas presence and high dividend yields, as well as Zhongxin Co. for its growth potential in Thailand [4][6][24] 2. Metal Packaging - The industry is facing pressure domestically, but overseas profitability remains strong. Companies are actively pursuing overseas expansion to counter domestic competition and improve profit margins [31][34] - Key players like Aorijin and Baosteel Packaging are enhancing their overseas sales ratios, with significant improvements in profit margins for exports compared to domestic sales [34][61] - Investment suggestions focus on Aorijin for its differentiated overseas strategy and Baosteel Packaging for its clear capacity expansion plans [4][6][34] 3. Plastic Packaging - The industry is shifting towards environmentally friendly and customized solutions, with companies like Yongxin Co. leading the way in functional film materials and expanding their overseas market presence [64][73] - The market for single-material plastic films is expected to grow significantly, driven by sustainability trends and increasing demand from multinational brands [70][73] - Investment recommendations highlight Yongxin Co. for its robust growth in functional film materials and stable revenue from overseas markets [4][6][73]

Group 1 - Yongtai Technology's wholly-owned subsidiary has received approval for trial production of a lithium battery additive project with an annual capacity of 5,000 tons, set to begin trial production [1] - Mengke Pharmaceutical has decided to terminate its plan to issue shares to a specific entity due to ongoing disagreements among major shareholders, which could impact the company's stable operations [1] - Anhui Construction's subsidiary has been approved to register and issue debt financing tools totaling 15 billion yuan, including 5 billion yuan in short-term financing notes and 10 billion yuan in medium-term notes [2] Group 2 - Koli'er plans to repurchase shares worth between 10 million and 20 million yuan, with a maximum repurchase price of 20.94 yuan per share, to implement an employee stock ownership plan [2] - Xinhua Pharmaceutical has received approval for the production of fumaric acid volnoral raw materials, which are used to treat gastroesophageal reflux disease [3] - Lianhuan Pharmaceutical has received approval for additional specifications of tadalafil tablets, expanding its product offerings for treating erectile dysfunction and benign prostatic hyperplasia [5] Group 3 - Greenland Holdings reported an increase of 1,834 lawsuits with a total amount of 6.587 billion yuan from October 21 to November 13, 2025 [7] - Lianke Technology plans to invest up to 600 million yuan of idle funds in low-risk financial products [8] - Yinglian Co. signed a strategic procurement contract for 5,000 million square meters of composite aluminum foil with a leading new energy technology company [10] Group 4 - China Eastern Airlines reported a 10.58% year-on-year increase in passenger turnover for October, with a capacity increase of 6.84% [12] - China National Airlines reported an 8.7% year-on-year increase in passenger turnover for October, with domestic and international capacity also showing growth [15] - Oupai Home plans to use 320 million yuan of idle funds to purchase structured deposits with expected annual yields between 0.65% and 2.50% [16] Group 5 - Tianwei Food has submitted H-share issuance application materials to the Hong Kong Stock Exchange, which have been accepted by the China Securities Regulatory Commission [18] - Guizhou Aviation plans to establish a subsidiary focused on the research, production, and market expansion of intelligent automotive components, with initial operating funds of 40 million yuan [20] - Daimai Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary in Shanghai focused on robotics technology [22] Group 6 - Founder Securities has received approval to issue company bonds totaling up to 30 billion yuan [24] - Hengrui Medicine has received clinical trial approvals for multiple drugs, indicating ongoing research and development efforts [26] - Zhaojing Pharmaceutical's product ZG006 has received orphan drug designation from the FDA, providing various benefits for its development in the U.S. market [39]

Group 1 - The company, Meiyingsen, announced a profit distribution plan for the first half of 2025, proposing a cash dividend of 0.66 RMB per 10 shares for all shareholders [2] - The total number of shares for the dividend calculation is 1,531,323,685 [2] - The record date for shareholders to receive the dividend is set for November 24, 2025, with the ex-dividend date on November 25, 2025 [2]

2025 年半年度权益分派实施公告 证券代码：002303 证券简称：美盈森 公告编号：2025-039 美盈森集团股份有限公司 2025 年半年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、股东大会审议通过利润分配方案的情况 二、权益分派方案 本公司2025年半年度权益分派方案为：以公司现有总股本1,531,323,685股为基数， 向全体股东每10股派0.660000元人民币现金（含税；扣税后，通过深股通持有股份的香 港市场投资者、境外机构（含QFII、RQFII） 以及持有首发前限售股的个人和证券投资 基金每10股派0.594000元；持有首发后限售股、股权激励限售股及无限售流通股的个人 股息红利税实行差别化税率征收，本公司暂不扣缴个人所得税，待个人转让股票时，根 据其持股期限计算应纳税额【注】；持有首发后限售股、股权激励限售股及无限售流通 股的证券投资基金所涉红利税，对香港投资者持有基金份额部分按10%征收，对内地投 资者持有基金份额部分实行差别化税率征收）。【注：根据先进先出的原则，以投资者 1 2025 年半年度权益分派实 ...

Core Viewpoint - Meiyingsen (002303) announced on November 14 that its product pricing strategy considers both costs and customer demands for product design and services, indicating a comprehensive approach to pricing [1] Group 1 - The company emphasizes that product pricing is influenced by multiple factors, including cost and customer needs [1]